Portal Biotechnologies, Inc. — Form D/A
Portal Biotechnologies, Inc. of ARLINGTON, MA, a company, filed a Form D amendment with the SEC on 2026-05-29. The offering totals $11.9M, of which $11.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-05-29
- Form: D/A
- Accession: 0002049466-26-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.9M
- Amount sold: $11.7M
- Remaining: $210K
- Minimum investment: $10K
- Investors: 43
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-533355
Issuer
- Name: Portal Biotechnologies, Inc.
- CIK: 0002049466
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 27 BRUNSWICK RD., ARLINGTON, MA, 02476
- Phone: 4152333357
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Alec Barlcay | Related Person | ARLINGTON, MA |
| Armon Sharei | Related Person | Arlington, MA |
| Alec Barlcay | Director | ARLINGTON, MA |
| Alec Barlcay | Executive Officer | ARLINGTON, MA |
| Armon Sharei | Director | Arlington, MA |
| Armon Sharei | Executive Officer | Arlington, MA |
Other filings by this issuer (2)
More